Evidence map›Paper›PMID 40610723›Full record

ArticleNature cancer2025

Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial.

Wen Lei, Hui Liu, Wenhai Deng, Wei Chen, Yun Liang, Wenxia Gao, Xianggui Yuan, Shanshan Guo, Ping Li, Jinyong Wang and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Wen Lei *Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Hui Liu *Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0003-1452-5062
Wenhai Deng *Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.ORCID http://orcid.org/0000-0003-3270-5980
Wei Chen *Stem Cell Translational Research Center, Tongji Hospital, Tongji University, School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0002-8375-518X
Yun LiangDepartment of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Wenxia GaoStem Cell Translational Research Center, Tongji Hospital, Tongji University, School of Medicine, Shanghai, China.
Xianggui YuanDepartment of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Shanshan GuoDepartment of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Ping LiDepartment of Hematology, Tongji Hospital of Tongji University, Shanghai, China.
Jinyong WangState Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Xiangmin TongDepartment of Hematology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China. tongxiangmin@163.com.ORCID http://orcid.org/0000-0002-4175-0321
Yi Eve SunStem Cell Translational Research Center, Tongji Hospital, Tongji University, School of Medicine, Shanghai, China. yi.eve.sun@gmail.com.ORCID http://orcid.org/0000-0002-1272-3295
Aibin LiangDepartment of Hematology, Tongji Hospital of Tongji University, Shanghai, China. lab7182@tongji.edu.cn.ORCID http://orcid.org/0000-0002-8978-1987
Wenbin QianDepartment of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. qianwb@zju.edu.cn.ORCID http://orcid.org/0000-0002-9817-6674

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40610723
PMCPMC12296552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.